Cargando…
Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation
BACKGROUND: Cysteine-rich intestinal protein 1 (CRIP1) is highly expressed in human intestine and aberrantly expressed in several types of tumor. However, studies on CRIP1 are limited and its role on tumor development and progression remains controversial and elusive. METHODS: Immunohistochemistry w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408822/ https://www.ncbi.nlm.nih.gov/pubmed/30850009 http://dx.doi.org/10.1186/s13046-019-1117-z |
_version_ | 1783401859049848832 |
---|---|
author | Zhang, Lanzhi Zhou, Rui Zhang, Weibin Yao, Xueqing Li, Weidong Xu, Lijun Sun, Xuegang Zhao, Liang |
author_facet | Zhang, Lanzhi Zhou, Rui Zhang, Weibin Yao, Xueqing Li, Weidong Xu, Lijun Sun, Xuegang Zhao, Liang |
author_sort | Zhang, Lanzhi |
collection | PubMed |
description | BACKGROUND: Cysteine-rich intestinal protein 1 (CRIP1) is highly expressed in human intestine and aberrantly expressed in several types of tumor. However, studies on CRIP1 are limited and its role on tumor development and progression remains controversial and elusive. METHODS: Immunohistochemistry was performed to evaluate the expression of CRIP1 in paired normal and colorectal tumor specimens, as well as colorectal cell lines. Functional assays, such as CCK8, TUNEL assay and in vivo tumor growth assay, were used to detect the proliferation, apoptosis and response to 5-FU of CRIP1. Western blot was used to analyze Fas-mediated pathway induced by CRIP1. Rescue experiments were performed to evaluate the essential role of CRIP1 for Fas-mediated apoptosis. RESULTS: We demonstrated that CRIP1 is overexpressed in CRC tissues compared with adjacent normal mucosa. CRIP1 could dramatically recover the 5-Fluorouracil (5-FU) inhibited CRC cell proliferation in vitro and stimulate the tumor formation of CRC in vivo, probably through inhibiting CRC cell apoptosis. Moreover, CRIP1 also dramatically recovered the 5-Fluorouracil (5-FU) induced tumor cell apoptosis in vitro. Further study demonstrated that CRIP1 down-regulated the expression of Fas protein and proteins related to Fas-mediated apoptosis. CRIP1 could interact with Fas protein and stimulate its ubiquitination and degradation. In addition, a negative correlation was detected between the expression of CRIP1 and Fas protein in most of the clinical human CRC samples. CONCLUSION: The current research reveals a vital role of CRIP1 in CRC progression, which provide a novel target for clinical drug resistance of colorectal cancer and undoubtedly contributing to the therapeutic strategies in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1117-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6408822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64088222019-03-21 Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation Zhang, Lanzhi Zhou, Rui Zhang, Weibin Yao, Xueqing Li, Weidong Xu, Lijun Sun, Xuegang Zhao, Liang J Exp Clin Cancer Res Research BACKGROUND: Cysteine-rich intestinal protein 1 (CRIP1) is highly expressed in human intestine and aberrantly expressed in several types of tumor. However, studies on CRIP1 are limited and its role on tumor development and progression remains controversial and elusive. METHODS: Immunohistochemistry was performed to evaluate the expression of CRIP1 in paired normal and colorectal tumor specimens, as well as colorectal cell lines. Functional assays, such as CCK8, TUNEL assay and in vivo tumor growth assay, were used to detect the proliferation, apoptosis and response to 5-FU of CRIP1. Western blot was used to analyze Fas-mediated pathway induced by CRIP1. Rescue experiments were performed to evaluate the essential role of CRIP1 for Fas-mediated apoptosis. RESULTS: We demonstrated that CRIP1 is overexpressed in CRC tissues compared with adjacent normal mucosa. CRIP1 could dramatically recover the 5-Fluorouracil (5-FU) inhibited CRC cell proliferation in vitro and stimulate the tumor formation of CRC in vivo, probably through inhibiting CRC cell apoptosis. Moreover, CRIP1 also dramatically recovered the 5-Fluorouracil (5-FU) induced tumor cell apoptosis in vitro. Further study demonstrated that CRIP1 down-regulated the expression of Fas protein and proteins related to Fas-mediated apoptosis. CRIP1 could interact with Fas protein and stimulate its ubiquitination and degradation. In addition, a negative correlation was detected between the expression of CRIP1 and Fas protein in most of the clinical human CRC samples. CONCLUSION: The current research reveals a vital role of CRIP1 in CRC progression, which provide a novel target for clinical drug resistance of colorectal cancer and undoubtedly contributing to the therapeutic strategies in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1117-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-08 /pmc/articles/PMC6408822/ /pubmed/30850009 http://dx.doi.org/10.1186/s13046-019-1117-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhang, Lanzhi Zhou, Rui Zhang, Weibin Yao, Xueqing Li, Weidong Xu, Lijun Sun, Xuegang Zhao, Liang Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title | Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title_full | Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title_fullStr | Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title_full_unstemmed | Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title_short | Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation |
title_sort | cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated fas degradation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408822/ https://www.ncbi.nlm.nih.gov/pubmed/30850009 http://dx.doi.org/10.1186/s13046-019-1117-z |
work_keys_str_mv | AT zhanglanzhi cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT zhourui cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT zhangweibin cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT yaoxueqing cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT liweidong cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT xulijun cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT sunxuegang cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation AT zhaoliang cysteinerichintestinalprotein1suppressesapoptosisandchemosensitivityto5fluorouracilincolorectalcancerthroughubiquitinmediatedfasdegradation |